Non-genomic effects of tamoxifen on the activation of membrane-bound guanylate cyclase GC-A

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 11, 2003, Pages 1539-1545

  Chen, Zi Jiang ^a,b   Vetter, Michael ^a   Chang, Geen Dong ^c   Liu, Shiguo ^a   Ding, Yaxian ^a   Chang, Chung Ho ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANDONG UNIVERSITY   (China)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ATRIAL NATRIURETIC FACTOR; BACTERIAL TOXIN; CYCLIC GMP; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GUANYLATE CYCLASE; GUANYLATE CYCLASE A RECEPTOR; GUANYLATE CYCLASE B RECEPTOR; GUANYLATE CYCLASE C RECEPTOR; GUANYLIN; NATRIURETIC PEPTIDE TYPE C; PHYTOESTROGEN; RESVERATROL; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; CELL MEMBRANE; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ESCHERICHIA COLI; GENOMICS; HEAT; KIDNEY PROXIMAL TUBULE; NONHUMAN; RAT;

ANIMALS; CELL MEMBRANE; CELLS, CULTURED; CYCLIC GMP; ENZYME ACTIVATION; ESTRADIOL; ESTROGEN ANTAGONISTS; GASTROINTESTINAL HORMONES; GUANYLATE CYCLASE; KIDNEY TUBULES, PROXIMAL; NATRIURETIC PEPTIDES; PEPTIDES; SWINE; TAMOXIFEN;

EID: 0344013547     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357022089     Document Type: Article

References (39)

1. Aronica, S. M., Kraus, W. L., Katzenellenbogen, B. (1994) Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl Acad. Sci. USA 91: 8517-8521
2. Chang, C.-H., Song, D.-L. (1993) Melittin potentiates guanylate cyclase activation stimulated by atrial natriuretic factor and ATP. J. Biol. Chem. 268: 4908-4911
3. Chen, Z.-J., Yu, L., Chang, C.-H. (1998) Stimulation of membrane-bound guanylate cyclase activity by 17-β estradiol. Biochem. Biophys. Res. Commun. 252: 639-642
4. Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., Shaul, P. W. (1999) Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103: 401-406
5. Chen, Z.-J., Che, D., Chang, C.-H. (2000) Resveratrol activates membrane-bound guanylate cyclase in PC12 cells. Pharm. Pharmacol. Commun. 6: 211-215
6. Chen, Z.-J., Che, D., Vetter, M., Liu, S., Chang, C.-H. (2001a) 17β-Estradiol inhibits soluble guanylate cyclase activity through a protein tyrosine phosphatase in PC12 cells. J. Steroid Biochem. Mol. Biol. 78: 451-458
7. Chen, Z.-J., Che, D., Chang, C.-H. (2001b) Antioxidants, vitamin C and dithiothreitol, activate membrane-bound guanylate cyclase in PC12 cells. J. Pharm. Pharmacol. 53: 243-247
8. Clarke, R., Leonessa, F., Welsch, J. N., Skaar, T. C. (2001) Cellular and molecular pharmacology of antiestrogen action and resistance. Pharmacol. Rev. 53: 25-71
9. Custodio, J. B., Dinis, T. C., Almeida, L. M., Madeira, V. M. (1994) Tamoxifen and hydroxytamoxifen as intramembraneous inhibitors of lipid peroxidation. Evidence for peroxyl radical scavenging activity. Biochem. Pharmacol. 47: 1989-1998
10. Daniel, P., Gaskell, S. J., Bishop, H., Campbell, C., Nicholson, I. (1981) Determination of tamoxifen and biologically active metabolites in human breast tumors and plasma. Eur. J. Cancer Clin. Oncol. 17: 1183-1189
11. Dick, G. M., Rossow, C. F., Horowitz, B., Sanders, K. M. (2001) Tamoxifen activates smooth muscle BK channels through the regulatory b1 subunit. J. Biol. Chem. 276: 34594-34599
12. EI-Mowafy, A. M. (2002) Resveratrol activates membrane-bound guanylyl cyclase in coronary arterial smooth muscle: A novel signaling mechanism is support of coronary protection. Biochem. Biophys. Res. Commun. 291: 1218-1224
13. Etienne, M. C., Milano, G., Fischcel, J. L., Francois, E., Formento, J. L., Gioanni, J., Namer, M. (1989) Tamoxifen metabolism: Pharmacokinetic and in vitro study. Br. J. Cancer 60: 30-35
14. Filardo, E. J., Quinn, J. A., Bland, K. I., Frackelton, A. R. (2000) Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14: 1649-1660
15. Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freeman, L., Helzlsour, K., Vogel, V. (1999) Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J. Natl Cancer Inst. 91: 1829-1846
16. Hashimoto, M., Inoue, S., Muramatsu, M., Masliah, E. (1997) Estrogens stimulate tamoxifen-induced neuronal cell apoptosis in vitro: A possible nongenomic action. Biochem. Biophys. Res. Commun. 240: 464-470
17. Hong, P.K., Jee, Y. L., Jeongmi, K. J., Sung, W. B., Hong, K. L., Inho, J. (1999) Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor α localized in caveolae. Biochem. Biophys. Res. Commun. 263: 257-262
18. John, S. W. M., Krege, J. H., Oliver, P. M., Hagaman, J. R., Hodgin, J. B., Pang, S. C., Flynn, T. G., Smithies, O. (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681
19. Kauffman, R. E., Bryant, H. U. (1995) Selective estrogen receptor modulators. Drug News Perspect. 8: 531-539
20. Kaye, A. M., Spatz, M., Waisman, A., Sasson, S., Tamir, S., Vaya, J., Somjen, D. (2001) Paradoxical interactions among estrogen receptors, estrogens and SERMS: Mutual annihilation and synergy. J. Steroid Biochem. Mol. Biol. 76: 85-93
21. Kelley, M. J., Levin, E. R. (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12: 152-156
22. Kuohung, W., Shwaery, G. T., Keaney, J. F. (2001) Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cells. Am. J. Obstet. Gynecol. 184: 1060-1063
23. Lippman, S. M., Brown, P. H. (1999) Tamoxifen prevention of breast cancer: An instance of the fingerpost. J. Natl. Cancer Inst. 91: 1809-1819
24. Lonard, D. M., Smith, C. L. (2002) Molecular perspectives on selective estrogen receptor modulators (SERMs): Progress in understanding their tissue-specific agonist and antagonist actions. Steroids 67: 15-24
25. Lopez, M. J., Wong, S. K. F., Kishimoto, I., Dubois, S., Mach, V., Friesen, J., Garbers, D. L., Beuve, A. (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65-68
26. Migliaccio, A., Di Domenico, M., Castoria, G., De Falco, A., Bontempo, P., Nola, E., Auricchio, F. (1996) Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15: 1292-1300
27. Moss, R. T., Gu, Q., Wong, M. (1997) Estrogen: Nontranscriptional signaling pathway. Recent Progr. Hormone Res. 52: 33-69
28. Nadal, A., Ropero, A. B., Fuentes, E., Soria, B. (2001) The plasma membrane estrogen receptor: Nuclear or unclear? Trends Pharmacol. Sci. 22: 597-599
29. Nemere, I., Farach-Carson, M. C. (1998) Membrane receptors for steroid hormones: A case for specific cell surface binding sites for vitamin D metabolites and estrogens. Biochem. Biophys. Res. Commun. 248: 443-449
30. Oliver, P. M., Fox, J. E., Kim, R., Rockman, H. A., Kim, H. S., Reddick, R. L., Pandy, K. N., Milgram, S. L., Smithies, O., Maeda, N. (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl Acad. Sci. USA 94: 14730-14735
31. Oliver, P. M., John, S. W., Purdy, K. E., Kim, R., Maeda, N., Goy, M. F., Smithies, O. (1998) Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc. Natl Acad. Sci. USA 95: 2547-2551
32. Steinhelper, M. E., Cochrane, K. L., Field, L. J. (1990) Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16: 301-307
33. Thangaraju, M., Vijayalakshmi, T., Sachdanandam, P. (1994) Effect of tamoxifen on lipid peroxide and antioxidative system in postmenopausal women with breast cancer. Cancer 74: 7-82
34. Trump, D. L., Smith, D. C., Ellis, P. G., Rogers, M. P., Schold, S. C., Winer, E. P., Panella, T. J., Jordan, V. C., Fine, R. L. (1992) High-dose of tamoxifen, a potential multidrug-resistant reversal agent: Phase I trial in combination with vinblastine. J. Natl Cancer Inst. 84: 1811-1816
35. Valverde, M. A., Hardy, S. P., Diax, M. (2002) Activation of Maxi Cl(-) channels by antiestrogens and phenothiazines in NIH3T3 fibroblasts. Steroids 67: 439-445
36. Watters, J. J., Campbell, J. S., Cunningham, M. J., Krebs, E. G., Dorsa, D. M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein tyrosine kinase signaling cascade and c-fos immediate early gene transcription. Endocrinology 138: 4030-4033
37. Wedel, B. J., Garbers, D. L. (2001) The guanylyl cyclase family at Y2K. Annu. Rev. Physiol. 63: 215-233
38. Wiseman, H., Laughton, M. J., Arnstein, H. R., Cannon, M., Halliwell, B. (1990) The antioxidant action of tamoxifen and its metabolites. Inhibition of lipid peroxidation. FEBS Lett. 263: 192-194
39. Wiseman, H. (1995) Tamoxifen as an antioxidant and cardioprotectant. Biochem. Soc. Symp. 61: 209-19